COVID Update: Scripps provides COVID-19 tests only for patients with moderate to severe symptoms, and at-risk patients with mild symptoms. Read our FAQs.

KUSI Interviews Scripps Urologist on New Prostate Cancer Study

Ramdev Konijeti, MD, discusses the keys to proper active surveillance

Dr-Konijeti-KUSI-screen-shot-2015

Ramdev Konijeti, MD, discusses the keys to proper active surveillance

A recent study showed that most men who opt for active surveillance for their prostate cancer rather than treatment are not undergoing sufficient monitoring. Scripps Health urologist Ramdev Konijeti, MD, recently appeared on KUSI-TV News to discuss the study and how men can avoid potential shortcomings of active surveillance.

Media Contact

Stephen Carpowich
858-678-7183
carpowich.stephen@scrippshealth.org
Follow me: @Carpowich